Known information
- Senior Lecturer at Imperial College London
- World leader on the theoretical models behind our technology
About Nanograb
Nanograb, based in San Francisco and London, is a healthcare company specializing in drug discovery and delivery using AI to create targeted treatments. The team of three scientists, with extensive experience in antibody design, participated in Y Combinator's S23 batch and launched in 2023.